{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:06:53Z","timestamp":1781885213634,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":49,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:33:04Z","timestamp":1772022784000},"page":"495-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Alterations of bile acid composition in children with cystic fibrosis compared to healthy controls"],"prefix":"10.1016","volume":"25","author":[{"given":"Felix","family":"Escher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4886-0811","authenticated-orcid":false,"given":"Gerhard","family":"Liebisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Melter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0336-0581","authenticated-orcid":false,"given":"Thomas S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Knoppke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2492-8850","authenticated-orcid":false,"given":"Alexander","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jcf.2026.02.006_bib0001","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/MOG.0000000000000624","article-title":"Hepatic manifestations of cystic fibrosis","volume":"36","author":"Dana","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcf.2026.02.006_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"22","key":"10.1016\/j.jcf.2026.02.006_bib0003","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.3390\/ijms21228586","article-title":"Current treatment options for cystic fibrosis-related liver disease","volume":"21","author":"Staufer","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"03","key":"10.1016\/j.jcf.2026.02.006_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-1007159","article-title":"Liver and biliary problems in cystic fibrosis","volume":"18","author":"Colombo","year":"1998","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.jcf.2026.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1097\/HEP.0000000000000646","article-title":"Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations","volume":"79","author":"Sellers","year":"2024","journal-title":"Hepatology"},{"issue":"S1","key":"10.1016\/j.jcf.2026.02.006_bib0006","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ppul.27174","article-title":"Advanced cystic fibrosis liver disease: endovascular, endoscopic, radiologic, and surgical considerations","volume":"59","author":"Palle","year":"2024","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2026.02.006_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117599","article-title":"Cholic acid induces a cftr dependent biliary secretion and liver growth response in mice","volume":"10","author":"Bodewes","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jcf.2026.02.006_bib0008","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0000000000000432","article-title":"Liver disease in patients with cystic fibrosis","volume":"34","author":"Kamal","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcf.2026.02.006_bib0009","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.jcf.2017.07.006","article-title":"Gallbladder and bile duct disease in cystic fibrosis","volume":"16","author":"Assis","year":"2017","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2026.02.006_bib0010","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO3- umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jcf.2026.02.006_bib0011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/MOG.0b013e328352aab2","article-title":"The biliary HCO3 - umbrella: experimental evidence revisited","volume":"28","author":"Beuers","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.jcf.2026.02.006_bib0012","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1053\/j.gastro.2011.06.052","article-title":"Loss of CFTR affects biliary epithelium innate immunity and causes TLR4\u2013NF-\u03baB\u2014mediated inflammatory response in mice","volume":"141","author":"Fiorotto","year":"2011","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jcf.2026.02.006_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/MOG.0000000000000508","article-title":"Modifier genes in cystic fibrosis-related liver disease","volume":"35","author":"Debray","year":"2019","journal-title":"Curr Opin Gastroenterol"},{"issue":"10","key":"10.1016\/j.jcf.2026.02.006_bib0014","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/adc.50.10.769","article-title":"Aspects of bile acid metabolism in cystic fibrosis","volume":"50","author":"Goodchild","year":"1975","journal-title":"Arch Dis Child"},{"issue":"5","key":"10.1016\/j.jcf.2026.02.006_bib0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0016-5085(19)31852-9","article-title":"Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement","volume":"73","author":"Watkins","year":"1977","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jcf.2026.02.006_bib0016","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.33.3.387","article-title":"Biliary complications of cystic fibrosis","volume":"33","author":"O\u2019Brien","year":"1992","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jcf.2026.02.006_bib0017","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/liv.15544","article-title":"Increase of liver stiffness and altered bile acid metabolism after triple CFTR modulator initiation in children and young adults with cystic fibrosis","volume":"43","author":"Schnell","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jcf.2026.02.006_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(96)80326-6","article-title":"Bile acid kinetics and biliary lipid composition in cystic fibrosis","volume":"25","author":"Strandvik","year":"1996","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jcf.2026.02.006_bib0019","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1053\/j.gastro.2012.02.033","article-title":"Defects in gallbladder emptying and bile acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies","volume":"142","author":"Debray","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcf.2026.02.006_bib0020","unstructured":"Keil S.K. Evaluation der massenspektrometrischen analyse von Serumgallens\u00e4uren in der differentialdiagnostik (cholestatischer) Lebererkrankungen im Kindes-und Jugendalter und zum therapeutischen Drug monitoring der behandlung mit Ursodeoxychols\u00e4ure. 2017."},{"issue":"2","key":"10.1016\/j.jcf.2026.02.006_bib0021","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jcf.2018.02.006","article-title":"ECFS best practice guidelines: the 2018 revision","volume":"17","author":"Castellani","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2026.02.006_bib0022","first-page":"32","article-title":"Can the histologic changes of cystic Fibrosis-associated hepatobiliary disease be predicted by clinical criteria?","volume":"25","author":"Potter","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.jcf.2026.02.006_bib0023","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0168-8278(95)80444-7","article-title":"An ultrasound scoring system for the diagnosis of liver disease in cystic fibrosis","volume":"22","author":"Williams","year":"1995","journal-title":"J Hepatol"},{"issue":"30","key":"10.1016\/j.jcf.2026.02.006_bib0024","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J Chromatogr B"},{"issue":"22","key":"10.1016\/j.jcf.2026.02.006_bib0025","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1021\/acs.analchem.6b02596","article-title":"Relevance in the use of appropriate internal standards for accurate quantification using LC\u2013MS\/MS: tauro-conjugated bile acids as an example","volume":"88","author":"Krautbauer","year":"2016","journal-title":"Anal Chem"},{"key":"10.1016\/j.jcf.2026.02.006_bib0026","article-title":"German cystic fibrosis registry","author":"N\u00e4hrlich","year":"2023","journal-title":"Annu Rep."},{"issue":"2","key":"10.1016\/j.jcf.2026.02.006_bib0027","first-page":"214","article-title":"Excessive fecal taurine loss predisposes to taurine deficiency in cystic fibrosis","volume":"7","author":"Thompson","year":"1988","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"10.1016\/j.jcf.2026.02.006_bib0028","first-page":"1807","article-title":"Reference ranges of serum bile acids in children and adolescents","volume":"53","author":"Jahnel","year":"2015","journal-title":"Clin Chem Lab Med CCLM"},{"issue":"20","key":"10.1016\/j.jcf.2026.02.006_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012436","article-title":"Elevated levels of toxic bile acids in serum of cystic fibrosis patients with CFTR mutations causing pancreatic insufficiency","volume":"23","author":"Tabori","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jcf.2026.02.006_bib0030","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.20238","article-title":"Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis","volume":"39","author":"Smith","year":"2004","journal-title":"Hepatology"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326000366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:46:37Z","timestamp":1781883997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326000366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1569199326000366"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.02.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations of bile acid composition in children with cystic fibrosis compared to healthy controls","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}